Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies.
Loading...
Identifiers
Publication date
2019
Start date of the public exhibition period
End date of the public exhibition period
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Medizinische Genetik
Share
Abstract
Several externally blinded validation and implementation studies in the last 9 years have shown that it is now possible, through analysis of cell-free (cf) DNA in maternal blood, to effectively detect a high proportion of fetuses affected by trisomies 21, 18, and 13 at a much lower false-positive rate (FPR)
than all other existing screening methods. This article is aimed at reviewing technical and clinical considerations for implementing cfDNA testing in routine practice, including methods of analysis, performance of the test, models for clinical implementation, and interpretation of results.
Doctoral program
Description
Keywords
Cell-free DNA, Non-invasive prenatal testing, Trisomies, Prenatal screening, Aneuploidies